Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: J Neurochem. 2011 Mar 21;117(3):528–537. doi: 10.1111/j.1471-4159.2011.07224.x

Table 1.

Demographics of CSF training and test sets

A) Training Set
Disease group ALS DC HC
N 45 25 36
Sex: M:F 32:13 13:12 13:23
Age (Mean+/− St. Dev) 55.0 +/− 13.4 47.9 +/− 15.4 46.8 +/− 15.6
Site of onset Bulbar: Spine 7:37 (1 cognitive onset) N/A N/A
Median Disease duration 15.2 months N/A N/A
B) Test set
Disease group ALS DC HC
N 26 27 4
Sex M:F 11:9 16:11 2:2
Age (Mean +/− St. Dev) 55.1+/− 13.8 54.1 +/− 14.7 45.3 +/− 20.0
Bulbar : Limb 5:21 N/A N/A
Median Disease duration 17.8 months N/A N/A

Median disease duration represents the mean time from patient reported onset of clinical symptoms to the date when samples were collected.